The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 1 , Pages 44-51 , January 2007

Activation of protein C and hemodynamic recovery after coronary artery bypass surgery

  • Peter Raivio, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • Drs Fernández and Kuitunen contributed equally to this work.
    • Corresponding Author InformationAddress for reprints: Peter Raivio, MD, Department of Cardiothoracic Surgery, Helsinki University Central Hospital, Post box 340, FIN-00029 HUS, Helsinki, Finland
    • ,
  • Jose A. Fernández, MD, PhD

      Affiliations

    • Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, Calif
    • ,
  • Anne Kuitunen, MD, PhD

      Affiliations

    • Department of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • John H. Griffin, PhD

      Affiliations

    • Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, Calif
    • ,
  • Riitta Lassila, MD, PhD

      Affiliations

    • Department of Hematology, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Jari Petäjä, MD, PhD

      Affiliations

    • Department of Pediatrics, Jorvi Hospital, Helsinki University Central Hospital, Espoo, Finland.

Received 31 May 2006 ,Revised 11 August 2006 ,Accepted 2 October 2006.

References 

  1. Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1:1343–1348
  2. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol. 2004;24:1374–1383
  3. Griffin JH. Blood coagulation (The thrombin paradox). Nature. 1995;378:337–338
  4. Taylor FB, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987;79:918–925
  5. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  6. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, et al. Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med. 2003;31:834–840
  7. Levi M, Choi G, Schoots I, Schultz M, van der Poll T. Beyond sepsis: activated protein C and ischemia-reperfusion injury. Crit Care Med. 2004;32(suppl):S309–S312
  8. Liaw PC, Esmon CT, Kahnamoui K, Schmidt S, Kahnamoui S, Ferrell G, et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood. 2004;104:3958–3964
  9. Lindström O, Kylänpää L, Mentula P, Puolakkainen P, Kemppainen E, Haapiainen R, et al. Up-regulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Crit Care. 2006;10:R16.
  10. Raivio P, Kuitunen A, Suojaranta-Ylinen R, Lassila R, Petäjä J. Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage. J Thromb Haemost. 2006;4:1523–1529
  11. Petäjä J, Pesonen E, Fernandez JA, Vento AE, Rämö OJ, Griffin JH. Cardiopulmonary bypass and activation of antithrombotic plasma protein C. J Thorac Cardiovasc Surg. 1999;118:422–429
  12. Petäjä J, Pesonen E, Fernandez JA, Griffin JH, Repo H, Jansson SE, et al. Activated protein C and inflammation in human myocardium after heart surgery. Am J Hematol. 2001;67:210–212
  13. Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Early mortality in coronary bypass surgery: the EuroSCORE versus the Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg. 2004;77:1235–1239
  14. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood. 1992;79:2340–2348
  15. Ilmakunnas M, Pesonen EJ, Höckerstedt K, Mäkisalo H, Fernandez JA, Griffin JH, et al. Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation. Crit Care Med. 2006;34:426–432
  16. Turunen AJ, Fernandez JA, Lindgren L, Salmela KT, Kyllönen LE, Mäkisalo H, et al. Activated protein C reduces graft neutrophil activation in clinical renal transplantation. Am J Transplant. 2005;5:2204–2212
  17. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin JH, et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001;103:1799–1805
  18. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338–342
  19. Hirose K, Okajima K, Taoka Y, Uchiba M, Tagami H, Nakano K, et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg. 2000;232:272–280
  20. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood. 2000;95:3781–3787
  21. Schoots IG, Levi M, van Vliet AK, Maas AM, Roossink EH, van Gulik TM. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med. 2004;32:1375–1383
  22. Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation. 1991;84:293–299
  23. Takazoe K, Ogawa H, Yasue H, Sakamoto T, Oshima S, Arai H, et al. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction. Thromb Res. 1999;95:37–47
  24. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart. 2004;90:99–106

 Supported by a Finnish governmental special grant for health sciences research (Helsinki University Central Hospital grant no. TYH3237) and grants from the Finnish Angiology Society, the Research Foundation of Orion Corporation, and the Foundation for Pediatric Research.

PII: S0022-5223(06)01725-9

doi: 10.1016/j.jtcvs.2006.10.003

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 1 , Pages 44-51 , January 2007

Article Tools

* Image Usage & Resolution